Association Between Overactive Bladder and Polyneuropathy in Diabetic Patients
Nermin Tanik, Serhat Tanik, Sebahattin Albayrak, Kürsat Zengin, Levent Ertugrul Inan, Emel Kiyak Caglayan, Asuman Celikbilek, Kadir Kirboga, Mesut Gurdal
Int Neurourol J. 2016;20(3):232-239. Published online 2016 Sep 23 DOI: https://doi.org/10.5213/inj.1632508.254
Citations to this article as recorded by 
The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
Chung-Cheng Wang, Yung-Hong Jiang, Hann-Chorng Kuo
Toxins.2020; 12(3): 186. CrossRef
Physiopathology of the diabetic bladder
Tatiana Bolgeo, Antonio Maconi, Marinella Bertolotti, Annalisa Roveta, Marta Betti, Denise Gatti, Carmelo Boccafoschi
Archivio Italiano di Urologia e Andrologia.2020;[Epub] CrossRef
NLRP3 Promotes Diabetic Bladder Dysfunction and Changes in Symptom-Specific Bladder Innervation
Francis M. Hughes, Nathan A. Hirshman, Brian M. Inouye, Huixia Jin, Eloise W. Stanton, Chloe E. Yun, Leah G. Davis, Jonathan C. Routh, J. Todd Purves
Diabetes.2019; 68(2): 430. CrossRef
Overactive bladder in therapeutic practice: its association with cardiometabolic disorders
G. G. Sharvadze, B. U. Mardanov, R. A. Yandieva, M. N. Mamedov
Profilakticheskaya meditsina.2018; 21(6): 124. CrossRef
The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats
Didem Yilmaz-Oral, Nur Bayatli, Serap Gur
Urology.2017; 107: 271.e1. CrossRef